Joshua LaBaer, MD, Ph.D.

Biodesign Institute

Francis Eshun, MD

Hematology/Oncology

David Carpentieri, MD

Pathology

Looking to identify the phosphorylation sites of a protein over expressed in high risk/poor outcome neuroblastoma patients